Champions Oncology Inc
NASDAQ:CSBR

Watchlist Manager
Champions Oncology Inc Logo
Champions Oncology Inc
NASDAQ:CSBR
Watchlist
Price: 7.22 USD -4.62% Market Closed
Market Cap: 99.9m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one CSBR stock under the Base Case scenario is 6.59 USD. Compared to the current market price of 7.22 USD, Champions Oncology Inc is Overvalued by 9%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CSBR Relative Value
Base Case
6.59 USD
Overvaluation 9%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.7
P/S
P/S
Price to Sales
1.7
vs History
57
vs Industry
61
Median 3Y
1.5
Median 5Y
2
Industry
3.8
Forward
1.7
More Details
15.4
P/E
P/E
Price to Earnings
15.4
vs History
38
vs Industry
Median 3Y
-7.9
Median 5Y
-7.9
Industry
30.6
Forward
23.4
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
35
Median 3Y
-10.8
Median 5Y
10
Industry
18.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
14
Median 3Y
-11.3
Median 5Y
-15.4
Industry
32.2
More Details
18.1
P/B
P/B
Price to Book Value
18.1
vs History
42
vs Industry
100
Median 3Y
11.7
Median 5Y
17
Industry
2.5
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
53
vs Industry
57
Median 3Y
1.4
Median 5Y
1.9
Industry
3.6
Forward
1.7
More Details
3.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.2
vs History
66
vs Industry
58
Median 3Y
3.2
Median 5Y
3.7
Industry
8.2
More Details
12
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12
vs History
47
vs Industry
3
Median 3Y
-9
Median 5Y
10.6
Industry
16.9
Forward
15.8
More Details
15.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
15.2
vs History
38
vs Industry
Median 3Y
-7.5
Median 5Y
-7.5
Industry
23
Forward
28.3
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
38
Median 3Y
-10.3
Median 5Y
7.9
Industry
17.6
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
15
Median 3Y
-10.6
Median 5Y
-10.6
Industry
23.1
More Details
4.3
EV/IC
EV/IC
Enterprise Value to IC
4.3
vs History
50
vs Industry
11
Median 3Y
3.9
Median 5Y
4.7
Industry
2.3
More Details

Multiples Across Competitors

CSBR Competitors Multiples
Champions Oncology Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Champions Oncology Inc
NASDAQ:CSBR
99m USD 1.7 15.4 12 15.2
US
PerkinElmer Inc
LSE:0KHE
1T USD 377.4 3 647.4 1 278.9 2 608.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
154.1B USD 3.6 23.7 16.6 22.9
US
Danaher Corp
NYSE:DHR
142.3B USD 6 37.8 20.8 30.3
KR
Samsung Biologics Co Ltd
KRX:207940
70.9T KRW 14.5 55.4 32.2 44.7
CH
Lonza Group AG
SIX:LONN
39.6B CHF 6 62.2 22.8 35.6
US
Agilent Technologies Inc
NYSE:A
33.6B USD 5.1 28.8 19.5 23.1
US
IQVIA Holdings Inc
NYSE:IQV
27.3B USD 1.8 20.5 11.4 16.9
CN
WuXi AppTec Co Ltd
SSE:603259
190.1B CNY 4.6 17 16.3 16.3
US
Mettler-Toledo International Inc
NYSE:MTD
24.4B USD 6.4 28.8 21.4 23.8
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.8B EUR 6.9 96.9 30.8 54.6

See Also

Summary
CSBR intrinsic value, competitors valuation, and company profile.
DCF Valuation
CSBR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CSBR stock valuation using valuation multiples.
Wall Street Estimates
CSBR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CSBR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 264,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.